A retrospective study of tisagenlecleucel therapy in children less than three years of age for B-ALL
Latest Information Update: 22 Jun 2022
At a glance
- Drugs Tisagenlecleucel (Primary) ; CAR-T cell therapies
- Indications Precursor B-cell lymphoblastic leukaemia-lymphoma
- Focus Adverse reactions; Therapeutic Use
- 01 Jun 2022 Results published in the Leukemia
- 03 Aug 2021 New trial record
- 17 Jun 2021 Results presented at the 26th Congress of the European Haematology Association